ICL Group Ltd (ICL) Q4 2025 Earnings Call Transcript

ICL Group Ltd (ICL) Q4 2025 Earnings Call Transcript

Seeking Alpha • Feb 18, 2026

ICL Reports Fourth Quarter and Full Year 2025 Results

TEL AVIV, Israel & ST. LOUIS--(BUSINESS WIRE)--ICL (NYSE: ICL) (TASE: ICL), a leading global specialty minerals company, today reported its financial results for the fourth quarter and full year ended December 31, 2025. For the fourth quarter, consolidated sales of $1,701 million were up 6% versus $1,601 million in the fourth quarter of 2024. Operating income was ($16) million versus $147 million, while adjusted operating income of $223 million was up 17% versus $190 million in 2024. Adjusted E.

Business Wire • Feb 18, 2026

ICL Announces Fourth Quarter 2025 Earnings Call

TEL AVIV, Israel & ST. LOUIS--(BUSINESS WIRE)--ICL (NYSE: ICL) (TASE: ICL), a leading global specialty minerals company, today announced it plans to release fourth quarter 2025 results prior to the opening of the TASE market on Wednesday, February 18, 2026. On that day, Elad Aharonson, president and CEO of ICL, and Aviram Lahav, CFO of ICL, will host a conference call to discuss results, provide a general business update and answer questions at 8:30 a.m. New York time (1:30 p.m. London and 3:30.

Business Wire • Jan 29, 2026

ICL Group Ltd (ICL) M&A Call Transcript

ICL Group Ltd (ICL) M&A Call Transcript

Seeking Alpha • Jan 28, 2026

ICL Group (ICL) Upgraded to Buy: Here's Why

ICL Group (ICL) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Zacks Investment Research • Jan 16, 2026

ICL Strengthens Food Ingredients Platform With Bartek Acquisition

ICL Group strikes a two-stage deal to buy Bartek Ingredients, adding food-grade acidulants and boosting its specialty food solutions platform.

Zacks Investment Research • Dec 23, 2025

ICL Group Expands Further into Global Food Ingredients with Acquisition of Bartek Ingredients

TEL AVIV, Israel & ST. LOUIS--(BUSINESS WIRE)--ICL (NYSE: ICL) (TASE: ICL) today announced it has entered into a definitive agreement to acquire Bartek Ingredients. Bartek is the global leader in food-grade malic and fumaric acid and serves hundreds of customers and distributors in the food, beverage, confectionery, bakery and other end-markets worldwide. These functional food ingredients are used by food and beverage companies to enhance flavor profiles, extend shelf life and improve overall q.

Business Wire • Dec 18, 2025

ICL Group Ltd (ICL) Q3 2025 Earnings Call Transcript

ICL Group Ltd ( ICL ) Q3 2025 Earnings Call November 12, 2025 8:30 AM EST Company Participants Peggy Tharp - Vice President of Global Investor Relations Elad Aharonson - President & CEO Aviram Lahav - Chief Financial Officer Conference Call Participants Benjamin Theurer - Barclays Bank PLC, Research Division Kevin Estok - Jefferies LLC, Research Division Joel Jackson - BMO Capital Markets Equity Research Presentation Operator Good morning, ladies and gentlemen, and welcome to ICL Third Quarter 2025 Earnings Call. [Operator Instructions] This call is being recorded on Wednesday, November 12, 2025.

Seeking Alpha • Nov 12, 2025

ICL Reports Third Quarter 2025 Results and Announces New Strategic Principles

TEL AVIV, Israel & ST. LOUIS--(BUSINESS WIRE)--ICL (NYSE: ICL) (TASE: ICL), a leading global specialty minerals company, today reported its financial results for the third quarter ended September 30, 2025. Consolidated sales were $1.9 billion, up $100 million versus the prior year. Operating income was $230 million versus $214 million in the third quarter of last year, with adjusted operating income of $241 million versus $243 million. For the third quarter, net income attributable to sharehold.

Business Wire • Nov 12, 2025

ICL Group (ICL) Beats Q3 Earnings Estimates

ICL Group (ICL) came out with quarterly earnings of $0.1 per share, beating the Zacks Consensus Estimate of $0.09 per share. This compares to earnings of $0.11 per share a year ago.

Zacks Investment Research • Nov 12, 2025